Session 8: Pregnancy Flashcards

1
Q

Describe Implantation (quick recap)

A

By the time the blastocyst enters the uterine cavity (4-5 days after fertilisation), the endometrium (simple columnar) is ready to receive it for pregnancy to be established. After a day or so in the uterine cavity, the blastocyst implants into the endometrium.

[*] The syncytiotrophoblast is good at transport

[*] The cytotrophoblast is the stem cell layer – increases size of syncytiotrophoblast and carries out repair.

  • Implantation involves interaction between trophoblast cells and the epithelium of the uterus.
  • Further embedding of the blastocyst into the endometrium is dependent upon the invasive property of the trophoblasts, which by now has an outer layer called the Syncytiotrophoblast differentiated from the underlying Cytotrophoblast.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What has happened by the 10th day after fertilisation? Describe the early placenta

A

By the 10th day after fertilisation, the blastocyst is fully embedded within the endometrium.

[*] The uterine gland secretes a large number of secretions/

[*] Implantation is interstitial: uterine epithelium is breached and conceptus implants within stroma.

[*] Placental membrane becomes progressively thinner as the needs of the foetus increase.

[*] Placenta is haemochorial: one layer of trophoblast ultimately separates maternal blood from fetal capillary wall (optimizing transport)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What has happened by the end of Week 2? What happens next?

A

Initially the chorionic sac and the amniotic sac are separate but as the embryo enlarges and the volume of amniotic fluid increases, this leads to the amniotic sac making more contact with the chorionic sac. The villi recede – become restricted to a zone and become specialised for function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the aims of implantation?

A

[*] Establish the basic unit of exchange

  • Primary villi: early, finger-like simple projections of trophoblast
  • Secondary villi: invasion of mesenchyme into core (as differentiation occurs)
  • Tertiary villi: invasion of mesenchyme core by fetal vessels

[*] Anchor the placenta

  • Establishment of outermost cytotrophoblast shell (foetal and maternal tissues are enclosed)

[*] Establish maternal blood flow within the placenta (around chorionic villi to optimise transport)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe the histology of implantation

A

[*] The endometrium is prepared for implantation

Decidualisation

  • Pre-Decidual cells
  • The decidual reaction provides the balancing force for the invasive force of the trophoblast.
  • Stimulated by progesterone
  • Without this balancing force, complications such as haemorrhage can occur e.g. in ectopic pregnancy and conditions characterised by excessive invasion (starting to invade myometrium)
  • Remodelling of Spiral Arteries (elaboration of spiral arterial blood supply)
    • Creation of low resistance vascular bed
    • Maintains the high flow required to meet fetal demand, particularly late in gestation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe what happens when implantation goes wrong - including ectopic pregnancy, placenta praevia, and incomplete invasion of trophoblast

A

[*] Ectopic pregnancy

  • Implantation at site other than uterine body
  • Most commonly fallopian tube
  • Can be peritoneal or ovarian
  • Can very quickly become a life-threatening emergency

[*] Placenta Praevia

  • Implantation in the lower uterine segment
  • Can cause haemorrhage in pregnancy
  • Requires C-section delivery

[*] Incomplete Invasion of trophoblast

  • Placental insufficiency
  • Pre-Eclampsia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How may twinning occur at different stages?

A

Twinning: the degree to which membranes are shared in monozygotic twins can vary

[*] Two morulas and blastocysts => separate implantation sites => 2 amnions and two chorions

[*] One morula => 2 ICMs and bilaminar discs => 2 amnions but a shared chorion

[*] One blastocyst and bilaminar disc => amnion and chorion are both shared => 2 primitive streaks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the development of the placenta

A
  • A good placenta determines a good pregnancy. It represents the interface between the mother and developing child, the structure through which nutrients are supplied from the mother and waste is removed from the embryo/foetus.
  • It has a developmental programme in its own right and its structure changes over time in ways that reflect the changes in function required of it.
  • Development of the placenta begins soon after fertilisation at compaction, with cells of the outer cell mass destined to develop into the structures that support the embryo/fetus during the pregnancy.

[*] The embryo/fetus is enclosed by the amnion and chorion membranes in a protective sac, and the placenta develops as a specialisation of outer membrane, the chorion.

[*] This specialisation begins as implantation gets underway and takes the form of finger-like projections, called chorionic villi.

[*] These villi are the functional units of the placenta and represent the point of exchange between the maternal and foetal circulations.

[*] In essence, the chorionic villi consist of a vascularised core covered by 2 epithelial layers.

As the placenta matures to meet the increasing demands of the growing fetus, it adapts by decreasing the interhaemal distance. This is achieved by thinning of the trophoblast layer(s), margination of the fetal capillaries of the core of the villi and increasing the surface area for exchange through increased branching of the villus tree.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What happens when development of the placenta goes wrong?

A

[*] These processes become exaggerated in situations where the demand for transported materials or restriction on the maternal side leads to a deficit.

[*] For example, placentae from pregnancies in women who smoke or live at high altitude have reduced interhaemal distances when compared to “normal”.

[*] Of course, this compensation has a limit and there are circumstances when the placenta’s powers of compensation are exceeded.

[*] Placental defects are among the major risk factors for intrauterine growth restriction, and impaired fetal growth has been linked to long-term adult health problems (Barker hypothesis – the fetal origins of adult disease)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe the components of the placenta by the beginning of the 4th month

A
  1. A foetal position
  • Formed by the chorion frondsum
  • Bordered by the chorionic plate
  1. A maternal portion
  • Formed by the decidua basalis
  • The decidual plate is most intimately incorporated into the placenta

[*] Between the chorionic and decidual plates are the Intervillous Spaces, which are filled with maternal blood.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What happens to the placenta during the fourth and fifth months?

A
  • During the fourth and fifth months, the decidua forms a number of Decidual Septa, which project into the intervillous spaces but do not reach the chorionic plate. These septa divide the placenta into a number of compartments or Cotyledons.
  • As a result of the continuous growth of the fetus and expansion of the uterus, the placenta also enlarges. Throughout pregnancy it covers approximately 15-30% of the internal surface of the uterus.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe the placental barrier during first trimester, at term and at parturition

A

First Trimester Placenta

[*] Placenta established

[*] Placental ‘barrier’ (‘leaky sieve’) to diffusion still relatively thick.

[*] Complete cytotrophoblast layer beneath syncytiotrophoblast

Term Placenta

[*] Surface area for exchange dramatically increased

[*] Placental ‘barrier’ is now thin (transport is now very efficient)

[*] Cytotrophoblast layer beneath syncytiotrophoblast lost (as its only job was to repair syncytiotrophoblast – now no longer continuous)

The placenta is shed at parturition and the massive blood supply to the implantation site is shut down. If the placenta fragments during labour, this can result in retained placenta which impairs shut-down of the utero-placental circulation, and consequently can cause serious post-partum haemorrhage.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the arrangement of fetal blood vessels within the placenta

A

The umbilical arteries and veins project into tertiary villi, which are bathed in oxygenated maternal blood.

  • Two Umbilical Arteries: carries deoxygenated blood from fetus => placenta
  • One Umbilical Vein: carries oxygenated blood from placenta => fetus

Cotyledons receive their blood through 80-100 spiral arteries that pierce the decidual plate.

[*] Pressure in these arteries forces oxygenated blood deep into the intervillous spaces and bathes the numerous small villi of the villous tree in oxygenated blood.

[*] As the pressure decreases, blood flows back from chorionic plate towards the decidua, where it enters the endometrial veins.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the factors influencing the passive diffusion of substances across the placenta

A

Materno-fetal exchange occurs through a variety of means, and involves both simple and facilitated diffusion, active transport and receptor-mediated endocytosis. The combined utero-placental and fetal-placental circulations represent a counter-current supply that ensures that materno-fetal exchange is efficient and simply regulated.

[*] Concentration Gradient: the steeper the gradient, the more diffusion

[*] Barrier to diffusion: placental membrane gradually thins throughout pregnancy as the demand of the fetus increases

[*] Diffusion distance: haemochorial.

The placenta represents a selective barrier to the fetal circulation that regulates access to the fetal circulation and affords considerable protection from harmful agents. However, this barrier is not complete and can be breached either by simple “leakage” or a number of infectious agents may utilise existing transport systems (e.g. HIV), active penetrate (e.g. Treponema) or opportunistically exploit gaps in the epithelium (e.g. Toxoplasma).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

List some teratogens and organisms that can cross the placenta

A

Teratogens can access the fetus via the placenta, giving physiological consequences. Teratogens are particularly damaging during critical stages of development

[*] Thalidomide
[*] Alcohol

[*] Therapeutic drugs particularly anticonvulsants

[*] Drugs of abuse

[*] Maternal smoking

Some pathogens are also able to cross the placenta:

[*] Varicella zoster

[*] Cytomegalovirus

[*] Treponema pallidum

[*] Toxoplasma gondii

[*] Rubella (=> microcephaly, patent ductus arteriosus and cataracts)

In addition to nutrient supply and waste removal, the placenta is responsible for the endocrine support of pregnancy and the provision of passive immunity that affoirds immune protection in the neonatal period.
Things can also go wrong due to unintentional outcomes from physiological processes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Name molecules that travel across the placenta by simple diffusion, facilitated diffusion and active transport

A

Simple Diffusion: molecules moving down a concentration gradient

[*] Water
[*] Electrolytes

[*] Urea and uric acid

[*] Gases

Flow-limited, not diffusion-limited (dependent on optimum flow in uteroplacental circulation)
Fetal O2 stores are small – maintenance of adequate flow is essential

At term ~300 ml in maternal lakes

Facilitated Diffusion

[*] Glucose

Active Transport: specific transporters are expressed by the syncytiotrophoblast

[*] Amino acids

[*] Iron
[*] Vitamins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What protein hormones are produced by the placenta? What are their roles?

A

[*] Human Chorionic Gonadotrophin (hCG)

  • Produced during the first two months of pregnancy
  • Supports the secretory function of the corpus luteum
  • Produced by syncytiotrophoblast, therefore is pregnancy specific.
  • Excreted in maternal urine therefore used as the basis for pregnancy testing.
  • Trophoblast disease
Molar pregnancy (hydatidiform mole)  (placenta and foetus do not form properly – a non-viable fertilized egg implants in the uterus and will fail to come to term).
Choriocarcinoma (malignant, trophoblastic cancer, usually of the placenta but may also arise in the testis or ovary – ‘germ cell tumour’)

[*] Human Chorionic Somatommotrophin (hCS) aka human placental lactogen (hPL)

  • Influences maternal metabolism, increasing the availability of glucose to the fetus (optimal transport)

[*] Human Chorionic Thyrotrophin

[*] Human Chorionic Cortiotrophin

18
Q

What steroid hormones are produced by the placenta?

A

Steroid hormones from the placenta are responsible for maintaining the pregnant state. Placental production takes over from corpus luteum by the 11th week.

[*] Progesterone:

Influences maternal metabolism by increasing appetite (major role in early part of pregnancy, planning for the future by laying down fat stores)

[*] Oestrogen

19
Q

Apart from hormones, what else is produced in the placenta?

A

The placenta also synthesises glycogen, cholesterol and fatty acids.

20
Q

Describe the hormonal basis of testing for pregnancy

A

Human Chorionic Gonadotrophin (hCG)

[*] Produced during the first two months of pregnancy

[*] Supports the secretory function of the corpus luteum

[*] Produced by syncytiotrophoblast, therefore is pregnancy specific.

[*] Excreted in maternal urine, therefore is used as the basis for pregnancy testing.

21
Q

Describe the function of the placenta as a provider of passive maternal immunity to the neonate

A

Passive Immunity: immunological competence begins to develop late in the first trimester, by which time the fetus makes all of the components of complement.
Fetal immunoglobulins consist almost entirely of maternal immunoglobulin (IgG), which begins to be transported from mother to fetus at approximately 14 weeks. (immunoglobulin class-specific)

[*] The IgG is transported via Receptor Mediated Pinocytosis. This process matures as pregnancy progresses.

[*] Eventually the concentration of IgG in fetal plasma exceeds that of maternal plasma

[*] In this manner, the fetus gains passive immunity against various infectious diseases. Newborns produce their own IgG, but adult levels are not attained until the age of 3.

22
Q

Describe Haemolytic Disease of the Newborn

A

Haemolytic Disease of the Newborn aka Rhesus disease

[*] Rhesus blood group incompatibility of mother and fetus

[*] Mother previously sensitised to rhesus antigen (D antigen expressed on the surface of RBCs) (e.g. in previous pregnancy)

[*] IgG antibodies against rhesus crosses the placenta and attacked foetal RBCs.

[*] Now uncommon because of prophylactic treatment

  • Rhesus-negative mothers pregnant with Rhesus-positive fetus given Rhesus specific IgG throughout pregnancy to prevent sensitisation in the event of exposure to the antigen (the given IgG will bind to antigen before the mother’s immune system can mount a response).

[*] Rhesus disease only affects the baby. The mother will not experience any symptoms. Depending on the severity, the baby may show anaemia and jaundice, perhaps hypotonia.

23
Q

Why does maternal adaptation in pregnancy occur?

A

Maternal adaptation to pregnancy involves extensive biochemical, physiological and structural changes in order to

  • Provide a suitable environment for the nutrition, growth and development of the fetus.
  • Prepare the mother for birth
  • Prepare the mother for support of the newborn.
24
Q

Describe the hormonal regulation of the maternal adaptation to pregnancy

A

hCG, progesterone, oestrogen, relaxin, hPL, inhibin

[*] hCG is released from trophoblastic cells (syncytiotrophoblasts) of the blastocyst peaking at 10 weeks gestation. hCG (human chorionic gonadotrophin) mimics the action of LH on the corpus luteum, hence preventing degeneration of the latter.

[*] Oestrogen and especially progesterone secretion is important in maintaining pregnancy

  • Progesterone stimulates appetite in the first half of pregnancy and diverts glucose into fat synthesis.
  • Oestrogen stimulates an increase in prolactin release.
25
Q

What physiological changes occur during pregnancy?

A

[*] Cardiovascular system

[*] Urinary system

[*] Respiratory system

[*] Metabolic changes

  • Carbohydrate
  • Thyroid hormones

[*] Gastrointestinal System

[*] Immune System

26
Q

Describe the changes in Carbohydrate Metabolism

A

(Glucose and Amino Acid Metabolism) Changes

[*] Glucose and amino acid metabolism are altered in pregnancy to favour nutritional supply to the fetus.

[*] The fat which is laid down in the first half of the pregnancy helps meet the demands of the fetus later in the pregnancy when the fetus is most demanding, metabolically.

[*] Progesterone stimulates appetite in the first half of pregnancy and diverts glucose into fat synthesis. Oestrogen stimulates an increase in prolactin release, which along with other hormones, generates a maternal resistance to insulin. Maternal glucose usage thus declines and gluconeogenesis increases, maximising availability of glucose to the fetus.

[*] The changes which occur include

  • Placental transport of glucose – facilitated diffusion
  • Reduction in maternal blood glucose and amino acid concentrations
  • Diminished maternal responsiveness to insulin (insulin resistance) in the second half of pregnancy – insulin resistance generated by several hormones (prolactin, hPL, glucose and cortisol, possibly also oestrogen and progesterone). Mother switches to gluconeogenesis and alternate fuels - increase in maternal free fatty acid, ketone and triglyceride levels (as an alternative metabolic fuel).
  • Increased insulin release in response to a normal meal
  • Decrease in fasting blood glucose
  • Increase in post-meal (post pandial) blood glucose

[*] These changes are achieved through the combined actions of human placental lactogen (hPL AKA human chorionic somatomammotrophin, hCS), oestrogen, progesterone and prolactin.

[*] Maternal glucose usage thus declines and gluconeogenesis increases, maximizing availability of glucose to the fetus. In later pregnancy, the mother’s energy needs are by metabolizing peripheral fatty acids.

27
Q

What happens in Gestational Diabetes?

A

Carbohydrate intolerance first recognised in pregnancy and do not persist after delivery.
Risks associated with poor control (persistently elevated blood glucose)

  • Macrosomic fetus => problems during labour and delivery
  • Stillbirth
  • Increased risk of congenital defects

Oral glucose tolerance test required
Maternal insulin is a major factor in controlling the metabolic response to pregnancy. The rate of secretion of insulin (both basal and stimulated) normally increases as pregnancy proceeds. The ability of pancreatic beta-cells to meet this increased demand for insulin secretion is achieved by beta-cell hyperplasia and hypertrophy as well as the increased rate of insulin synthesis in the beta-cell.
In some women, the endocrine pancreas is unable to respond to the metabolic demand of pregnancy, and the pancreas fails to release the increased amounts of insulin required. As a consequence there is a loss of control of metabolism, blood glucose increases and diabetes results (Gestational Diabetes).
After birth, when the increased metabolic demands of pregnancy are removed and hormone levels change, the endocrine pancreas can respond adequately and the diabetes disappears. Women who experience gestational diabetes are more likely to develop other diabetes later in life.

28
Q

Describe the changes in Lipid Metabolism

A
  • Increase in lipolysis from T2
  • Increase in plasma concentration of free fatty acids on fasting
    • Free fatty acids provide substrate for maternal metabolism, leaving glucose for the fetus. Free fatty acids do not cross the placenta apart from essential fatty acids.
  • Increased utilisation of free fatty acids increases the risk of ketoacidosis
    • Combined with the pregnancy’s state of compensated respiratory alkalosis, this can be extremely bad.
29
Q

Describe the changes in Thyroid Metabolism

A

Thyroid binding globulin production increased in liver, which is matched by increased T3 and T4

  • Free T4 in normal range due to increased binding globulin.

hCG has a direct effect on the thyroid, stimulating T3 and T4 production

  • TSH can be decreased in normal pregnancies as a result of negative feedback from T3 and T4 produced due to hCG secretion
30
Q

Describe the maternal Cardiovascular changes that occur during pregnancy

A

[*] As pregnancy advances, the fetal-placental unit’s increasing need for nutrition is met via maternal vascular-neogenesis. This is accommodated by changes in function of the maternal baro- and volume receptors.

[*] There is also increased blood flow to the growing breasts, kidneys and GI tract (increased metabolism).

[*] Plasma (blood) volume increases (but this increase isn’t matched exactly by increase in Hb => physiological anaemia (not pathological) whilst peripheral vascular resistance often falls during pregnancy.

  • Increased volume leads to auscultatory systolic murmurs.
  • Diaphragm moves up => displacement of the apex beat, changes on ECG.
  • These changes are physiological NOT pathological

[*] Cardiac output increases

[*] Stroke volume increases

[*] Heart rate increases

[*] NB: CO = HR x SV

[*] Systolic BP is never increased in pregnancy (normally) – due to decrease in systematic vascular resistance. This can mask pre-existing hypertension.

31
Q

Describe hypotension in pregnancy

A
  • T1 and T2: progesterone effects on systemic vascular resistance (SVR) – causes smooth muscle relaxation.
  • T3: aortocaval compression by gravid uterus (enlarged uterus, has pushed diaphragm up etc). Reduced return to the heart. Risk of impairment of the utero-circulation when in supine position. Mechanical problem rather than physiological.
32
Q

Describe the changes in the Respiratory System during pregnancy

A

[*] Anatomical changes

  • Diaphragm is displaced
  • AP and transverse diameters of thorax increase.

[*] O2 consumption increases 20%

[*] Decreased functional residual capacity

[*] Vital capacity unchanged (increase in tidal volume is balanced by decrease in functional residual capacity)

[*] Pulmonary function is not impaired by pregnancy but diseases of the respiratory system may be more serious in pregnancy largely due to the increased oxygen requirement of gestation.

[*] The respiratory rate is little changed but tidal volume and oxygen uptake increase appreciably.

[*] Alveolar ventilation rate increased (due to increased tidal volume) but no change in respiratory rate

[*] Respiratory minute volume increased

[*] An increased awareness of the desire to breathe is common in pregnancy (physiological hyperventilation driven by progesterone), and may be interpreted as dyspnoea. The mechanism is felt to be the increase in tidal volume that lowers the pCO2 (so the mother can blow off the extra CO2 the fetus metabolically produces).

[*] This leads to respiratory alkalosis initially, which the kidneys compensate for by producing and reabsorbing less bicarbonate => reduced buffering capacity => greater predisposition to metabolic acidosis.

[*] The increased respiratory effort and the reduction in pCO2 are induced by progesterone acting directly on the respiratory centre and sensitizing chemoreceptors to CO2 changes.

33
Q

Describe changes in Renal Function (Urinary System)

A

[*] Increased renal plasma flow, raises the glomerular filtration rate to ~55% of normal (increased secretion of renin, aldosterone and angiotensin II compensate for the expected sodium loss).

  • Mechanism unclear but progesterone has been implicated
  • Renal plasma flow increases more than GFR up to T3, so you get a decreased filtration fraction up to T3.

[*] Filtration capacity intact

[*] Functional renal reserve decreases as GFR increases (the system is stretched to its capacity).

[*] Urinary system: progesterone relaxes the smooth muscle in the walls of the ureters, which can result in stasis, hydroureter, UTIs and pyelonephritis. Urinary stasis could also lead to obstruction.

  • Pyelonephritis can induce pre-term labour.

[*] Note it is important to know normal-for-pregnancy range for urea and creatinine because standard ‘normal’ levels could be an indication for significant renal impairment.

34
Q

How is Calcium Metabolism affected?

A

[*] The placenta also contributes to the maternal synthesis of DHCC (1, 25 dihydroxycholecalciferol or calcitriol).

35
Q

Describe the GI changes during pregnancy

A

[*] Anatomical Changes

  • Alterations in the positions of viscera e.g. appendix moves from RLQ to LUQ as the uterus enlarges so abdomen examination will change.

[*] Physiological Changes

Smooth muscle relaxation by progesterone

  • GI – delayed emptying
  • Biliary tract – stasis (secondary effect)
  • Pancreas – increased risk of pancreatitis.

There are small changes in bile salt composition => will lead to increased risk of stone formation.

36
Q

Describe the Haematological changed during pregnancy and anaemia

A

[*] Pregnancy is a Pro-Thrombotic State (body is anticipating and preparing for blood loss at delivery)

  • High amount of fibrin deposition at the site of implantation
    • Increased fibrinogen and clotting factors
    • Reduced fibrinolysis
  • Stasis and venodilation also occur
  • Results in thromboembolic disease in pregnancy
  • Cannot give warfarin – crosses the placenta and is teratogenic

[*] Anaemia

  • Plasma volume increases
  • RBC mass also increases, but not to the same degree
  • Physiological anaemia
  • Not a true anaemia, just a mismatch between volume and haemocrit
  • Anaemia due to iron and folate deficiency can also occur
  • Also haemoglobinopathies can occur.
37
Q

Describe the changes in the Immune System that occur during pregnancy

A

[*] Fetus is an allograft

  • Genetically different to mother

[*] Non-specific suppression of the local immune response at the materno-fetal interface (natural killer cells in endometrium behave differently etc)

[*] Transfer of antibodies

  • IgG crosses the placenta

[*] Haemolytic disease

  • Antibodies for ABO do not cross
  • Antibodies for Rhesus do cross

[*] Graves’ disease and Hashimoto’s Thyroiditis

  • Antibodies will cross the placenta (as they are of IgG-class) and either stimulate TSH receptors on or destroy developing fetal thyroid respectively.
38
Q

What is involved in Antenatal Screening?

A

[*] History and examination

  • Risk factors e.g. for gestational diabetes

[*] Blood test

  • Blood group
  • Haemoglobin
  • Infection e.g. HIV, syphilis

[*] Urinalysis

  • Protein – can indicate presence of UTI/renal failure, indication of future potential potential problems e.g. pre-eclampsia.
39
Q

Describe the role of the endothelium in pregnancy and pre-eclampsia

A

Endothelium in pregnancy

[*] Controls vascular permeability

[*] Contributes to the control of vascular tone

Pre-Eclampsia / Eclampsia

[*] Normal pregnancy circulation

  • Vasodilated (normal) endothelium
  • Plasma-expanded
  • Blood pressure not raised in normal pregnancy

[*] ** Pre-Eclamptic Pregnancy circulation**

  • Vasoconstricted
  • Plasma-contracted
  • Raised blood pressure
  • Proteinuria (indicates end-organ damage)
  • Pitting oedema

Eclampsia

[*] Defect in placentation => poor uteroplacental circulation => widespread endothelial dysfunction (systemic, not restricted to uterus)

40
Q

What are the hallmark features of pre-eclampsia?

A

[*] Historically pre-eclampsia has been defined as the triad of hypertension, proteinuria and oedema in a pregnant woman.

[*] Pre-eclampsia typically occurs in the third trimester of pregnancy, although some cases may manifest earlier.

[*] The disorder is really a spectrum of clinical signs and symptoms that accompany microvascular changes in multiple organ systems.

[*] CNS involvement can result in severe headaches, visual changes, seizures, stroke and blindness.

[*] Renal involvement is almost always present and can manifest as proteinuria, oliguria or renal failure.

[*] Oedema can accumulate in many sites, including the feet, hands, face and lungfs.

[*] Haemoconcentration, thrombocytopenia and intravascular haemolysis are common signs of haematological involvement.

[*] Hepatic dysfunction often accompanies haematological changes and produces a group of clinical findings known as HELLP syndrome (haemolysis, elevated liver function tests, low platelets). Patients with HELLP will often develop vague epigastric pain that may be mistaken for heart-burn, gallbladder disease or the flu.

41
Q

What are the hallmark clinical features of anaemia in pregnancy?

A

Anaemia commonly occurs in pregnancy.

[*] Pregnancy causes many changes in the haematological system, including an increase in both plasma volume and red cell mass; the former is greater than the latter with the result that a ‘physiological anaemia’ often occurs. There is an increased iron and folate demand to facilitate both the increase in red cell mass and fetal requirements, which is not always met by maternal diet. Iron deficiency anaemia is thus a common condition encountered in pregnancy, particularly in the third trimester.

[*] Anaemia is often identified as the result of routine full blood count measurements. Some women will present with symptoms such as SOB and lethargy. There is a variation in normal Hb levels in pregnancy and a gradual fall as pregnancy progresses. Anaemia can be diagnosed with a **Hb level less than 11g/dL in the first trimester and less than 10.5 g/dL in the second and third trimesters. **

42
Q

What are the hallmark clinical features of gestational diabetes?

A

[*] Gestational diabetes may be asymptomatic. As such, a screening programme needs to be in place that either be universal or selective (offered to at-risk groups such as previous large infant, previous gestational diabetes, first degree relative with diabetes, obesity, specific ethnic background e.g. South Asian etc.).

Screening is by an 75g oral glucose tolerance test at 28 weeks, or if very high risk, early in the second trimester and then repeated at 28 weeks (if normal at the first test).

In OGTT, a fasting glucose level is first measured, then a 75g loading dose of glucose is given and a further glucose level taken at 2 hours post-sugar load.

[*] Gestational diabetes is predominantly a disease of the third and sometimes second trimester. In the mother, the presence of gestational diabetes increases the risk of recurrent infections and of pre-eclampsia developing. For the fetus there is increased risk of polyhydraminos and macrosomia (related to the degree of glucose control). There is an increased risk of stillbirth.

[*] If vaginal birth occurs, shoulder dystocia, instrumental birth and extended perineal tears are common. Shoulder dystocia is a specific case of obstructed labour – the anterior shoulder of the infant cannot pass below, or requires significant manipulation to pass below the pubic symphysis. It is an obstetric emergency, and fetal demise can occur if the infant is not delivered, due to the compression of the umbilical cord within the birth canal.

[*] Women are more likely to have a caesarean section.

[*] Babies are at increased risk of neonatal hypoglycaemia due to the relative over-activity of the fetal pancreas in utero. This is less likely to occur if maternal blood sugars are well-controlled around the time of birth. Maternal glucose readily crosses the placenta whilst insulin does not.